- HOME
- Future Medical EXPO【Hosted by Osaka Prefecture】 -The world-leading ecosystem of Osaka-Kansai-
Future Medical EXPO【Hosted by Osaka Prefecture】
-The world-leading ecosystem of Osaka-Kansai-

Osaka Prefecture is promoting the industrialization of future healthcare,including regenerative medicine, with the International Institute of Future Medicine, Nakanoshima Qross(NQ), at its core.
This symposium aims to showcase the technological capabilities and life science potential of Osaka and the Kansai region, as well as the appeal of NQ, to both domestic and international audiences. The goal is to expand investment opportunities in Osaka and Kansai.
The event will feature lectures by key figures such as Dr. Yoshiki Sawa, a leader in the practical application of regenerative medicine, along with international experts and specialists from medical venture capital firms. In addition, life science startups will present future medical pitches.
Networking programs will also be held at the venue to foster interaction among participants.
概要OVERVIEW
- Date
- October 3, 2025 (Friday)
13:00~17:30
- Capacity
Up to 300 participants
- Venue Name
Square323 Congres Square Osaka Nakanoshima
- Venue Access URL
- Participation Fee
Free
- Hosted by
Osaka Prefectural Government
- Application Deadline
【on-site】September 24, 2025( Wednesday)
【online】October 3, 2025 (Friday) ※Until the end of the event
In the event that the number of applications exceeds capacity, participants will be selected through a lottery.
Notification of the results, whether successful or not, will be sent to your registered email address on Wednesday, September 25.
All online registrants will have access to view the event.
- Contact the Secretariat
E-mail: event.kansai@nks.co.jp
- Note
This event is being conducted by the Future Medical Information Dissemination Project Consortium—comprising Nikkei Inc. and Nikkeisha,Inc.—under commission from the Osaka Prefectural Government.
Program
13:00~13:05 Opening Remarks
13:05~13:10 Guest Remarks
13:10~13:30 Keynote Speech
13:30~14:00 Presentation
14:00~14:30 Presentation
14:30~15:00 Presentation
15:10~16:00 Future Medical Pitch
Healthcare Startups based in Osaka
16:00~17:00 Panel Discussion
President and CEO, Agatha Inc. Chiemi Kamakura
President and CEO, MIYATA INSTITUTE of TECHNOLOGIES Mitsuru Miyata
17:00~17:30 Networking Session
*Please note that the program and lecture content are subject to change without prior notice.
Speaker

Hirofumi Yoshimura
Governor of Osaka Prefecture

Yoshiki Sawa
President of the Organization of Future Medicine
Graduated from Osaka University School of Medicine in 1980 and joined the First Department of Surgery at the same university. Studied in Germany as a Humboldt Foundation Fellow at the Max Planck Institute, specializing in cardiac physiology and cardiac surgery.
Previously served as Professor and Chair of Cardiovascular and Thoracic Surgery at Osaka University Graduate School of Medicine, Director of the Center for Advanced Medical Innovation at Osaka University Hospital, Dean of Osaka University School of Medicine, President of the Japanese Society for Regenerative Medicine, and President of the Japanese Association for Thoracic Surgery.
Currently serves as President of the Organization for the Promotion of Future Medicine, Director of Osaka Police Hospital, and Professor Emeritus at Osaka University. He is also scheduled to serve as President of the 32nd Japan Medical Congress in 2027. Recipient of the Medal with Purple Ribbon in 2020.

Shinichiro Komoto
Partner, Eight Roads Ventures Japan
With deep expertise in the healthcare space, Shinichiro has led healthcare investments at Eight Roads Ventures Japan since 2017. Before that, during his long tenure at Mitsui & Co., he gained hands-on experience in healthcare investments, M&A, and managing subsidiaries across the U.S., Asia, and Japan.
Today, as an outside director of several portfolio companies, he works closely with founders—helping them scale globally. Passionate about nurturing Japanese healthcare startups with worldwide potential, he brings both strategy and support to the table. He holds a B.S. in Electrical Engineering from Tokyo Metropolitan University and completed an executive education program at INSEAD.

Brenda Kwak
Professor, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva
Born May 19, 1966, is a Professor in the Department of Pathology and Immunology at the Faculty of Medicine, University of Geneva, Switzerland.
She studied medicine at the University of Amsterdam and obtained her Ph.D. in Medical Physiology from the same university in 1993. After completing postdoctoral training at Utrecht University and the University of Geneva, she established her own research group in Switzerland in 2003 with support from the Swiss National Science Foundation (SNSF) professorship program.
Dr. Kwok’s research primarily focuses on the role of intercellular communication in cardiovascular physiology and disease. In recent years, her work has expanded into translational research exploring the impact of hemodynamic forces in neurovascular disorders. She has authored over 150 scientific publications and serves on the scientific advisory boards of several organizations in the fields of physiology and cardiovascular research.
In 2020, Dr. Kwok joined the SNSF Research Council, contributing to grant evaluations, funding decisions, and serving as a panel chair. She has also been involved in shaping funding policies for the Biology and Medicine Division and the Specialised Committee for International Cooperation. In June 2024, she was elected Chair and President of this committee. In this role, Dr. Kwok aims to promote and optimize international scientific collaboration and exchange for the benefit of Swiss science, contributing to the development of SNSF’s international funding policies and overall strategy, including the design of funding schemes and evaluation methodologies.

Chiemi Kamakura
President and CEO, Agatha Inc. Chiemi
Born in 1974 in Aichi Prefecture, currently residing in Tokyo. After completing her graduate studies at Nagoya Institute of Technology, she joined the Ministry of Internal Affairs and Communications, specifically the Telecommunications Bureau. In 2001, she transitioned to Hitachi, Ltd., where she was responsible for developing new business initiatives and designing foundational solutions for pharmaceutical and medical institutions, as well as managing related projects.
In 2011, she became the Japan Country Manager for NextDocs Corporation, a U.S.-based venture specializing in document management systems for pharmaceutical companies. In October 2015, she founded Agatha Inc. and assumed the role of President and CEO. She holds an MBA from Rice University in the United States and also serves as a part-time lecturer at her alma mater, Nagoya Institute of Technology.
In November 2024, she was honored with two prestigious awards: the “Woman of the Year 2025” presented by Nikkei WOMAN, and the “Tokyo Woman CEO Award” in the Sustainable Growth category, hosted by the Tokyo Metropolitan Government.
Moderator: Mitsuru Miyata
President, Healthcare Innovation